SeedCrest, Inc. Competitors

Agriculture and DCM Shriram Limited are often spoken of in the same breath. When DCM Shriram Limited took over the management of Bioseed in 2002, the move was seen as yet another initiative by DCM Shriram Limited to create value in the farmlands of India and beyond. Huge investments in people, research labs and seed processing infrastructure followed the takeover. Today, Bioseed owns a vast pool of germplasm, among the richest in the world. The gene pool has sprouted one of the highest success rates in all of Asia. When expansion plans took root, Bioseed strengthened its operations in Vietnam and The Philippines and extended its coverage to Bangladesh, Laos, Myanmar,Nepal and Kenya. The company's pan-Asian spread allows cross-fertilization of ideas. The yield: Unique biotechnology-based solutions for the benefit of countries with similar climatic and soil conditions. The mission: Empowering farmers with high-yielding solutions of the future, from the right hybrids to better cultivation techniques. Bioseed is one of a handful of biotechnology companies with expertise across the board: Research and development, field and lab testing, data review, production, farm management and farmer interaction.

BioHarvest Sciences Inc. (Nasdaq: BHST) is a public biotech company that has developed a patented Botanical Synthesis platform technology capable of growing the active and beneficial compounds in fruit & plants, at an industrial scale, without the need to grow the plant itself. BioHarvest has invested 17 years and >$100M to develop our Botanical Synthesis Technology, which produces unique and patentable botanical compositions which contain a “target optimized” combination of the phyto-medicinal compounds (with high solubility and bio-availability) found in the original plant. No other company has developed a commercially viable plant cell culture platform at the industrial scale of BioHarvest. BioHarvest is focused on leveraging this platform technology across the following business units: 1. Biologics+ CDMO Services: BioHarvest is leveraging its Botanical Synthesis technology to allow global pharmaceutical, nutrition, cosmetics, and nutraceutical partners to develop proprietary compounds with unmatched predictability and consistency, manufactured at industrial scale under exclusive partnerships. 2. Direct to Consumer Business Anchored in Science: BioHarvest has built its own direct to consumer business of propriety botanical compositions. The first product, VINIA® was launched into the US in 2021 and has now exceeded 60,000 daily users (>$50M USD Revenue since 2021 launch). VINIA® contains multiple polyphenols, including Piceid Resveratrol, with an amount in each daily 400mg capsule that is equivalent to 1,000 grapes, resulting in a powerful nutraceutical that has been clinically proven (in a published double-blind placebo-controlled study), to significantly increase dilation of arteries. This increased dilation of arteries improves blood flow and the delivery of oxygen and nutrients to the body, tissue & organs.

www.greentech.com